Linda J. Bendall
Darcy Road
Westmead, NSW, Australia
Westmead, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Identification of sphingosine kinase 1 as a therapeutic target in B-lineage acute lymphoblastic leukaemia.
Journal: British journal of haematology
Published: January 24, 2018
Sphingosine kinase 2 supports the development of BCR/ABL-independent acute lymphoblastic leukemia in mice.
Journal: Biomarker research
Published: January 02, 2018
Bone Marrow Graft-Versus-Host Disease in Major Histocompatibility Complex-Matched Murine Reduced-Intensity Allogeneic Hemopoietic Cell Transplantation.
Journal: Transplantation
Published: March 21, 2017
Extracellular molecules in hematopoietic stem cell mobilisation.
Journal: International journal of hematology
Published: October 04, 2016
Temporal Tracking of Cell Cycle Progression Using Flow Cytometry without the Need for Synchronization.
Journal: Journal of visualized experiments : JoVE
Published: September 02, 2015
A Phase I/II Study of the mTOR Inhibitor Everolimus in Combination with HyperCVAD Chemotherapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 11, 2014
G-CSF: From granulopoietic stimulant to bone marrow stem cell mobilizing agent.
Journal: Cytokine & growth factor reviews
Published: May 20, 2014
Efficacy of dual PI-3K and mTOR inhibitors in vitro and in vivo in acute lymphoblastic leukemia.
Journal: Oncotarget
Published: April 08, 2014
Sphingosine kinase 2 promotes acute lymphoblastic leukemia by enhancing MYC expression.
Journal: Cancer research
Published: April 02, 2014
Silencer of death domains controls cell death through tumour necrosis factor-receptor 1 and caspase-10 in acute lymphoblastic leukemia.
Journal: PloS one
Published: December 02, 2013
Last Updated: 09/26/2026